These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 27073700)

  • 1. Amyloid-β-Induced Dysregulation of AMPA Receptor Trafficking.
    Guntupalli S; Widagdo J; Anggono V
    Neural Plast; 2016; 2016():3204519. PubMed ID: 27073700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AMPA-ergic regulation of amyloid-β levels in an Alzheimer's disease mouse model.
    Hettinger JC; Lee H; Bu G; Holtzman DM; Cirrito JR
    Mol Neurodegener; 2018 May; 13(1):22. PubMed ID: 29764453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of AMPA receptor trafficking at hippocampal synapses by beta-amyloid oligomers: the mitochondrial contribution.
    Rui Y; Gu J; Yu K; Hartzell HC; Zheng JQ
    Mol Brain; 2010 Mar; 3():10. PubMed ID: 20346152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta-amyloid accumulation in APP mutant neurons reduces PSD-95 and GluR1 in synapses.
    Almeida CG; Tampellini D; Takahashi RH; Greengard P; Lin MT; Snyder EM; Gouras GK
    Neurobiol Dis; 2005 Nov; 20(2):187-98. PubMed ID: 16242627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amyloid-β Induces AMPA Receptor Ubiquitination and Degradation in Primary Neurons and Human Brains of Alzheimer's Disease.
    Zhang Y; Guo O; Huo Y; Wang G; Man HY
    J Alzheimers Dis; 2018; 62(4):1789-1801. PubMed ID: 29614651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deregulation of excitatory neurotransmission underlying synapse failure in Alzheimer's disease.
    Paula-Lima AC; Brito-Moreira J; Ferreira ST
    J Neurochem; 2013 Jul; 126(2):191-202. PubMed ID: 23668663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-fibrillar beta-amyloid abates spike-timing-dependent synaptic potentiation at excitatory synapses in layer 2/3 of the neocortex by targeting postsynaptic AMPA receptors.
    Shemer I; Holmgren C; Min R; Fülöp L; Zilberter M; Sousa KM; Farkas T; Härtig W; Penke B; Burnashev N; Tanila H; Zilberter Y; Harkany T
    Eur J Neurosci; 2006 Apr; 23(8):2035-47. PubMed ID: 16630051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human Brain-Derived Aβ Oligomers Bind to Synapses and Disrupt Synaptic Activity in a Manner That Requires APP.
    Wang Z; Jackson RJ; Hong W; Taylor WM; Corbett GT; Moreno A; Liu W; Li S; Frosch MP; Slutsky I; Young-Pearse TL; Spires-Jones TL; Walsh DM
    J Neurosci; 2017 Dec; 37(49):11947-11966. PubMed ID: 29101243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amyloid beta peptides and glutamatergic synaptic dysregulation.
    Parameshwaran K; Dhanasekaran M; Suppiramaniam V
    Exp Neurol; 2008 Mar; 210(1):7-13. PubMed ID: 18053990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabotropic Glutamate Receptors in Alzheimer's Disease Synaptic Dysfunction: Therapeutic Opportunities and Hope for the Future.
    Srivastava A; Das B; Yao AY; Yan R
    J Alzheimers Dis; 2020; 78(4):1345-1361. PubMed ID: 33325389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Post-synaptic scaffolding protein interactions with glutamate receptors in synaptic dysfunction and Alzheimer's disease.
    Proctor DT; Coulson EJ; Dodd PR
    Prog Neurobiol; 2011 Apr; 93(4):509-21. PubMed ID: 21382433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oligomeric Aβ-induced synaptic dysfunction in Alzheimer's disease.
    Tu S; Okamoto S; Lipton SA; Xu H
    Mol Neurodegener; 2014 Nov; 9():48. PubMed ID: 25394486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ca
    Whitehead G; Regan P; Whitcomb DJ; Cho K
    Neuropharmacology; 2017 Jan; 112(Pt A):221-227. PubMed ID: 27561971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble oligomers of amyloid-β peptide disrupt membrane trafficking of α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor contributing to early synapse dysfunction.
    Miñano-Molina AJ; España J; Martín E; Barneda-Zahonero B; Fadó R; Solé M; Trullás R; Saura CA; Rodríguez-Alvarez J
    J Biol Chem; 2011 Aug; 286(31):27311-21. PubMed ID: 21665950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alzheimer's disease-associated neurotoxic mechanisms and neuroprotective strategies.
    Pereira C; Agostinho P; Moreira PI; Cardoso SM; Oliveira CR
    Curr Drug Targets CNS Neurol Disord; 2005 Aug; 4(4):383-403. PubMed ID: 16101556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amyloid-β effects on synapses and memory require AMPA receptor subunit GluA3.
    Reinders NR; Pao Y; Renner MC; da Silva-Matos CM; Lodder TR; Malinow R; Kessels HW
    Proc Natl Acad Sci U S A; 2016 Oct; 113(42):E6526-E6534. PubMed ID: 27708157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. β-Amyloid triggers aberrant over-scaling of homeostatic synaptic plasticity.
    Gilbert J; Shu S; Yang X; Lu Y; Zhu LQ; Man HY
    Acta Neuropathol Commun; 2016 Dec; 4(1):131. PubMed ID: 27955702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increasing the Receptor Tyrosine Kinase EphB2 Prevents Amyloid-β-induced Depletion of Cell Surface Glutamate Receptors by a Mechanism That Requires the PDZ-binding Motif of EphB2 and Neuronal Activity.
    Miyamoto T; Kim D; Knox JA; Johnson E; Mucke L
    J Biol Chem; 2016 Jan; 291(4):1719-1734. PubMed ID: 26589795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. {beta}-Amyloid impairs AMPA receptor trafficking and function by reducing Ca2+/calmodulin-dependent protein kinase II synaptic distribution.
    Gu Z; Liu W; Yan Z
    J Biol Chem; 2009 Apr; 284(16):10639-49. PubMed ID: 19240035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of calcineurin-mediated endocytosis and alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors prevents amyloid beta oligomer-induced synaptic disruption.
    Zhao WQ; Santini F; Breese R; Ross D; Zhang XD; Stone DJ; Ferrer M; Townsend M; Wolfe AL; Seager MA; Kinney GG; Shughrue PJ; Ray WJ
    J Biol Chem; 2010 Mar; 285(10):7619-32. PubMed ID: 20032460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.